Literature DB >> 15648547

Hypoglycemia in response to glucose and glucagon in insulinoma patients with a negative prolonged fast: functional and morphological properties.

P Wiesli1, C Schmid, A Perren, T Pfammatter, G A Spinas, U Keller.   

Abstract

A negative 72-h fast is usually considered to preclude the diagnosis of insulinoma. The aim of this study was to describe the functional and morphological properties of two exceptional patients with an insulinoma who had exhibited pre-operatively a negative 72-h fast. Despite the ability of tumor cells to turn off insulin secretion in response to low plasma glucose during 72 h of fasting, hyperinsulinemic hypoglycemia occurred in both patients in response to stimulation by classical secretagogues. Pre-operatively, both patients underwent oral and iv glucose challenge tests and iv glucagon stimulation test. Insulin secretion was rapidly stimulated by these secretagogues to an exaggerated extent and thereby caused hypoglycemia due to an insulin mass effect. In contrast to the common functional features during suppression and stimulation tests, the tumors differed widely with regard to insulin and proinsulin response to calcium during ASVS tests and morphological properties. In patient 1, the immunohistochemical proinsulin distribution pattern resembled that of normal beta-cells, i.e. the staining was restricted to the perinuclear area; insulin and proinsulin were not stimulated by calcium during the ASVS test. In patient 2, the proinsulin staining pattern was abnormal, i.e. proinsulin was also found in the periphery of tumor cells; insulin and proinsulin were stimulated by calcium. We conclude that normal or exaggerated rather than defective glucose sensing may explain hypoglycemia in these exceptional insulinoma patients. Different functional characteristics of these tumors can be correlated with distinct morphological properties.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15648547     DOI: 10.1007/BF03346277

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  11 in total

1.  The prolonged fast.

Authors:  F J Service; N Natt
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  Glucose-induced hypoglycaemia.

Authors:  P Wiesli; G A Spinas; T Pfammatter; L Krahenbuhl; C Schmid
Journal:  Lancet       Date:  2002-11-09       Impact factor: 79.321

3.  An insulinoma presenting with reactive hypoglycaemia.

Authors:  H Connor; J H Scarpello
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

4.  A glucose-responsive insulinoma.

Authors:  L Power
Journal:  JAMA       Date:  1969-02-03       Impact factor: 56.272

5.  Hypoglycemic disorders.

Authors:  F J Service
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

6.  Kinetic assay of beta-hydroxybutyrate in plasma with a COBAS-BIO centrifugal analyzer.

Authors:  J J Moore; M Marcus; S M Sax
Journal:  Clin Chem       Date:  1982-04       Impact factor: 8.327

7.  Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.

Authors:  A Perren; L P Weng; A H Boag; U Ziebold; K Thakore; P L Dahia; P Komminoth; J A Lees; L M Mulligan; G L Mutter; C Eng
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

8.  Intraarterial calcium stimulation test for detection of insulinomas.

Authors:  J L Doppman; D L Miller; R Chang; P Gorden; R C Eastman; J A Norton
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

9.  Case report: a glucose responsive insulinoma--implication for the diagnosis of insulin secreting tumors.

Authors:  R J Sjoberg; G S Kidd
Journal:  Am J Med Sci       Date:  1992-09       Impact factor: 2.378

10.  Topographic abnormalities of proinsulin to insulin conversion in functioning human insulinomas. Comparison of immunoelectron microscopic and clinical data.

Authors:  J Roth; P Komminoth; P U Heitz
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

View more
  4 in total

1.  Pancreas: Insulinoma--new insights into an old disease.

Authors:  Maria Vittoria Davì; Massimo Falconi
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

2.  Presentation, diagnostic features and glucose handling in a monocentric series of insulinomas.

Authors:  M Toaiari; M V Davì; L Dalle Carbonare; L Boninsegna; C Castellani; M Falconi; G Francia
Journal:  J Endocrinol Invest       Date:  2013-04-18       Impact factor: 4.256

3.  Metastatic Insulinoma Presenting With Postprandial Hypoglycemia.

Authors:  Monique Debrah Maher; Dimpi Nitin Desai; Mandeep Bajaj
Journal:  AACE Clin Case Rep       Date:  2022-03-23

4.  PROINSULIN-PREDOMINANT PANCREATIC NEUROENDOCRINE TUMOR-INDUCED HYPOGLYCEMIA AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY.

Authors:  Khary Edwards; Lori de La Portilla; Faryal S Mirza; Pooja Luthra
Journal:  AACE Clin Case Rep       Date:  2019-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.